James M. Cleary, MD, PhD: Increasingly, hospitals—including mine—have pathways that tell us what the recommended treatments are for our patients at a certain course in their illness. At my hospital, ...
Syma Iqbal, MD, shares final insights into the ESCC and GI cancer treatment landscape, emphasizing the utilization of key diagnostic tools and innovative treatment strategies. Syma Iqbal, MD: In terms ...
Over the past three decades, the American Cancer Society cites that CRC incidences among women under 50 has surged by approximately 50%, with the most significant increases observed in those aged ...